Table 2 Comparison of baseline characteristics in low and high CD4+ PD1+ AML patients
From: Clinical implications of aberrant PD-1 expression for acute leukemia prognosis
Variable | Total number (n = 57) | Low CD4+ PD-1+ (n = 28) | High CD4+ PD-1+ (n = 29) | Statistic | p |
|---|---|---|---|---|---|
Gender, n (%) | χ2 = 2.998 | 0.088 | |||
Male | 27 (47.37) | 11 (36.67) | 16 (59.26) | ||
Female | 30 (52.63) | 19 (63.33) | 11 (40.74) | ||
Risk, n (%) | – | 1.000 | |||
Low risk | 5 (15.62) | 3 (17.65) | 2 (13.33) | ||
Medium risk | 9 (28.12) | 5 (29.41) | 4 (26.67) | ||
High risk | 18 (56.25) | 9 (52.94) | 9 (60.00) | ||